{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:24:19Z","timestamp":1792801459066,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS099129"],"award-info":[{"award-number":["R01NS099129"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K24AG075234"],"award-info":[{"award-number":["K24AG075234"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-024-03830-w","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T09:02:28Z","timestamp":1725613348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Attitudes and beliefs towards medication burden and deprescribing in Parkinson disease"],"prefix":"10.1186","volume":"24","author":[{"given":"Thanh Phuong","family":"Pham Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Thibault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali G.","family":"Hamedani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison W.","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,6]]},"reference":[{"key":"3830_CR1","doi-asserted-by":"publisher","unstructured":"By the American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria(R) for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71 7:2052\u201381.\u00a0https:\/\/doi.org\/10.1111\/jgs.18372.","DOI":"10.1111\/jgs.18372"},{"issue":"5","key":"3830_CR2","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1093\/ageing\/afaa033","volume":"49","author":"DS Abraham","year":"2020","unstructured":"Abraham DS, Pham Nguyen TP, Hennessy S, Weintraub D, Gray SL, Xie D, et al. Frequency of and risk factors for potentially inappropriate medication use in Parkinson\u2019s disease. Age Ageing. 2020;49(5):786\u201392. https:\/\/doi.org\/10.1093\/ageing\/afaa033.","journal-title":"Age Ageing"},{"issue":"5","key":"3830_CR3","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.sapharm.2023.01.010","volume":"19","author":"E Sonnerstam","year":"2023","unstructured":"Sonnerstam E, Harlin F, Gustafsson M. Potentially inappropriate medications among elderly people with neurocognitive disorders - A nationwide register-based study using 3 different explicit criteria. Res Social Adm Pharm. 2023;19(5):758\u201363. https:\/\/doi.org\/10.1016\/j.sapharm.2023.01.010.","journal-title":"Res Social Adm Pharm"},{"issue":"1","key":"3830_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/jamaneurol.2018.2820","volume":"76","author":"S Mantri","year":"2019","unstructured":"Mantri S, Fullard M, Gray SL, Weintraub D, Hubbard RA, Hennessy S, et al. Patterns of Dementia Treatment and Frank Prescribing Errors in Older Adults With Parkinson Disease. JAMA Neurol. 2019;76(1):41\u20139. https:\/\/doi.org\/10.1001\/jamaneurol.2018.2820.","journal-title":"JAMA Neurol"},{"key":"3830_CR5","doi-asserted-by":"publisher","unstructured":"Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, et al. Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers. 2021;7 1:47; https:\/\/doi.org\/10.1038\/s41572-021-00280-3.","DOI":"10.1038\/s41572-021-00280-3"},{"issue":"7","key":"3830_CR6","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/BF00886877","volume":"243","author":"M Pondal","year":"1996","unstructured":"Pondal M, Del Ser T, Bermejo F. Anticholinergic therapy and dementia in patients with Parkinson\u2019s disease. J Neurol. 1996;243(7):543\u20136. https:\/\/doi.org\/10.1007\/BF00886877.","journal-title":"J Neurol"},{"issue":"2","key":"3830_CR7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/jnnp.2009.186239","volume":"81","author":"U Ehrt","year":"2010","unstructured":"Ehrt U, Broich K, Larsen JP, Ballard C, Aarsland D. Use of drugs with anticholinergic effect and impact on cognition in Parkinson\u2019s disease: a cohort study. J Neurol Neurosurg Psychiatry. 2010;81(2):160\u20135. https:\/\/doi.org\/10.1136\/jnnp.2009.186239.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3830_CR8","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.parkreldis.2019.06.022","volume":"65","author":"CT Hong","year":"2019","unstructured":"Hong CT, Chan L, Wu D, Chen WT, Chien LN. Antiparkinsonism anticholinergics increase dementia risk in patients with Parkinson\u2019s disease. Parkinsonism Relat Disord. 2019;65:224\u20139. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.06.022.","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"3830_CR9","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/phar.2305","volume":"39","author":"JJ Sheu","year":"2019","unstructured":"Sheu JJ, Tsai MT, Erickson SR, Wu CH. Association between Anticholinergic Medication Use and Risk of Dementia among Patients with Parkinson\u2019s Disease. Pharmacotherapy. 2019;39(8):798\u2013808. https:\/\/doi.org\/10.1002\/phar.2305.","journal-title":"Pharmacotherapy"},{"key":"3830_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2016.12.021","volume":"38","author":"E Reeve","year":"2017","unstructured":"Reeve E, Thompson W, Farrell B. Deprescribing: A narrative review of the evidence and practical recommendations for recognizing opportunities and taking action. Eur J Intern Med. 2017;38:3\u201311. https:\/\/doi.org\/10.1016\/j.ejim.2016.12.021.","journal-title":"Eur J Intern Med"},{"issue":"3","key":"3830_CR11","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.pec.2021.06.021","volume":"105","author":"NJ Ailabouni","year":"2022","unstructured":"Ailabouni NJ, Rebecca Weir K, Reeve E, Turner JT, Wilson Norton J, Gray SL. Barriers and enablers of older adults initiating a deprescribing conversation. Patient Educ Couns. 2022;105(3):615\u201324. https:\/\/doi.org\/10.1016\/j.pec.2021.06.021.","journal-title":"Patient Educ Couns"},{"key":"3830_CR12","doi-asserted-by":"publisher","unstructured":"Smolensky L, Amondikar N, Crawford K, Neu S, Kopil CM, Daeschler M, et al. Fox Insight collects online, longitudinal patient-reported outcomes and genetic data on Parkinson's disease. Sci Data. 2020;7 1:67; https:\/\/doi.org\/10.1038\/s41597-020-0401-2.","DOI":"10.1038\/s41597-020-0401-2"},{"issue":"9","key":"3830_CR13","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1111\/jgs.12418","volume":"61","author":"E Reeve","year":"2013","unstructured":"Reeve E, Wiese MD, Hendrix I, Roberts MS, Shakib S. People\u2019s attitudes, beliefs, and experiences regarding polypharmacy and willingness to Deprescribe. J Am Geriatr Soc. 2013;61(9):1508\u201314. https:\/\/doi.org\/10.1111\/jgs.12418.","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"3830_CR14","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1001\/jamainternmed.2018.4720","volume":"178","author":"E Reeve","year":"2018","unstructured":"Reeve E, Wolff JL, Skehan M, Bayliss EA, Hilmer SN, Boyd CM. Assessment of Attitudes Toward Deprescribing in Older Medicare Beneficiaries in the United States. JAMA Intern Med. 2018;178(12):1673\u201380. https:\/\/doi.org\/10.1001\/jamainternmed.2018.4720.","journal-title":"JAMA Intern Med"},{"key":"3830_CR15","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.2147\/PPA.S323846","volume":"15","author":"I Buzancic","year":"2021","unstructured":"Buzancic I, Dragovic P, Pejakovic TI, Markulin L, Ortner-Hadziabdic M. Exploring Patients\u2019 Attitudes Toward Deprescribing and Their Perception of Pharmacist Involvement in a European Country: A Cross-Sectional Study. Patient Prefer Adherence. 2021;15:2197\u2013208. https:\/\/doi.org\/10.2147\/PPA.S323846.","journal-title":"Patient Prefer Adherence"},{"key":"3830_CR16","unstructured":"U.S. Census Bureau. Census Bureau Releases New Educational Attainment Data. https:\/\/www.census.gov\/newsroom\/press-releases\/2023\/educational-attainment-data.html (2023). Accessed January 4 2024."},{"issue":"3","key":"3830_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1177\/2010105817699633","volume":"26","author":"WL Ng","year":"2017","unstructured":"Ng WL, Tan MZW, Koh EYL, Tan NC. Deprescribing: What are the views and factors influencing this concept among patients with chronic diseases in a developed Asian community? Proceedings of Singapore Healthcare. 2017;26(3):172\u20139. https:\/\/doi.org\/10.1177\/2010105817699633.","journal-title":"Proceedings of Singapore Healthcare"},{"key":"3830_CR18","doi-asserted-by":"publisher","unstructured":"Kua CH, Reeve E, Tan DSY, Koh T, Soong JL, Sim MJL, et al. Patients' and Caregivers' Attitudes Toward Deprescribing in Singapore. J Gerontol A Biol Sci Med Sci. 2021;76 6:1074; https:\/\/doi.org\/10.1093\/gerona\/glaa062.","DOI":"10.1093\/gerona\/glaa062"},{"key":"3830_CR19","doi-asserted-by":"publisher","unstructured":"Crutzen S, Abou J, Smits SE, Baas G, Hugtenburg JG, Heringa M, et al. Older people's attitudes towards deprescribing cardiometabolic medication. BMC Geriatr. 2021;21 1:366; https:\/\/doi.org\/10.1186\/s12877-021-02249-z.","DOI":"10.1186\/s12877-021-02249-z"},{"issue":"6","key":"3830_CR20","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1111\/jgs.17730","volume":"70","author":"ME Growdon","year":"2022","unstructured":"Growdon ME, Espejo E, Jing B, Boscardin WJ, Zullo AR, Yaffe K, et al. Attitudes toward deprescribing among older adults with dementia in the United States. J Am Geriatr Soc. 2022;70(6):1764\u201373. https:\/\/doi.org\/10.1111\/jgs.17730.","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"3830_CR21","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s40266-019-00712-6","volume":"36","author":"M Edelman","year":"2019","unstructured":"Edelman M, Jellema P, Hak E, Denig P, Blanker MH. Patients\u2019 Attitudes Towards Deprescribing Alpha-Blockers and Their Willingness to Participate in a Discontinuation Trial. Drugs Aging. 2019;36(12):1133\u20139. https:\/\/doi.org\/10.1007\/s40266-019-00712-6.","journal-title":"Drugs Aging"},{"key":"3830_CR22","doi-asserted-by":"publisher","unstructured":"Tegegn HG, Tefera YG, Erku DA, Haile KT, Abebe TB, Chekol F, et al. Older patients' perception of deprescribing in resource-limited settings: a cross-sectional study in an Ethiopia university hospital. BMJ Open. 2018;8 4:e020590; https:\/\/doi.org\/10.1136\/bmjopen-2017-020590.","DOI":"10.1136\/bmjopen-2017-020590"},{"issue":"6","key":"3830_CR23","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/bcpt.13874","volume":"133","author":"A Pereira","year":"2023","unstructured":"Pereira A, Ribeiro O, Verissimo M. Predictors of older patients\u2019 willingness to have medications deprescribed: A cross-sectional study. Basic Clin Pharmacol Toxicol. 2023;133(6):703\u201317. https:\/\/doi.org\/10.1111\/bcpt.13874.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"3830_CR24","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1212\/WNL.0000000000004764","volume":"90","author":"N Dahodwala","year":"2018","unstructured":"Dahodwala N, Shah K, He Y, Wu SS, Schmidt P, Cubillos F, et al. Sex disparities in access to caregiving in Parkinson disease. Neurology. 2018;90(1):e48\u201354. https:\/\/doi.org\/10.1212\/WNL.0000000000004764.","journal-title":"Neurology"},{"issue":"2","key":"3830_CR25","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ncl.2022.12.001","volume":"41","author":"R Patel","year":"2023","unstructured":"Patel R, Kompoliti K. Sex and Gender Differences in Parkinson\u2019s Disease. Neurol Clin. 2023;41(2):371\u20139. https:\/\/doi.org\/10.1016\/j.ncl.2022.12.001.","journal-title":"Neurol Clin"},{"issue":"8","key":"3830_CR26","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1002\/mdc3.13347","volume":"8","author":"MJ Barrett","year":"2021","unstructured":"Barrett MJ, Sargent L, Nawaz H, Weintraub D, Price ET, Willis AW. Antimuscarinic Anticholinergic Medications in Parkinson Disease: To Prescribe or Deprescribe? Mov Disord Clin Pract. 2021;8(8):1181\u20138. https:\/\/doi.org\/10.1002\/mdc3.13347.","journal-title":"Mov Disord Clin Pract"},{"issue":"14","key":"3830_CR27","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/archinternmed.2009.229","volume":"169","author":"I Carriere","year":"2009","unstructured":"Carriere I, Fourrier-Reglat A, Dartigues JF, Rouaud O, Pasquier F, Ritchie K, et al. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med. 2009;169(14):1317\u201324. https:\/\/doi.org\/10.1001\/archinternmed.2009.229.","journal-title":"Arch Intern Med"},{"key":"3830_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k1315","volume":"361","author":"K Richardson","year":"2018","unstructured":"Richardson K, Fox C, Maidment I, Steel N, Loke YK, Arthur A, et al. Anticholinergic drugs and risk of dementia: case-control study. BMJ. 2018;361: k1315. https:\/\/doi.org\/10.1136\/bmj.k1315.","journal-title":"BMJ"},{"issue":"8","key":"3830_CR29","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1001\/jamainternmed.2019.0677","volume":"179","author":"CAC Coupland","year":"2019","unstructured":"Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study. JAMA Intern Med. 2019;179(8):1084\u201393. https:\/\/doi.org\/10.1001\/jamainternmed.2019.0677.","journal-title":"JAMA Intern Med"},{"issue":"3","key":"3830_CR30","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.trci.2017.06.004","volume":"3","author":"YF Chuang","year":"2017","unstructured":"Chuang YF, Elango P, Gonzalez CE, Thambisetty M. Midlife anticholinergic drug use, risk of Alzheimer\u2019s disease, and brain atrophy in community-dwelling older adults. Alzheimers Dement (N Y). 2017;3(3):471\u20139. https:\/\/doi.org\/10.1016\/j.trci.2017.06.004.","journal-title":"Alzheimers Dement (N Y)"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03830-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-024-03830-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03830-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T09:04:11Z","timestamp":1725613451000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-024-03830-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3830"],"URL":"https:\/\/doi.org\/10.1186\/s12883-024-03830-w","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,6]]},"assertion":[{"value":"30 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board (IRB) of the University of Pennsylvania approved this survey (protocol #833498). The New England IRB approved the Fox Insight study. All Fox Insight participants gave informed consent, and if unable, a legal guardian gave consent by proxy at enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Pham Nguyen was a member of the 2022-2023 Junior Investigator Intensive Program of the U.S. Deprescribing Research Network, which was funded by the National Institute on Aging [Grant # R24AG064025] and receives support from the National Institute of Health [Grants #1RF1NS132673-01,\u00a0#R01NS099129, #R01AG02515215, #R01AG06458903] and Acadia Pharmaceuticals Inc., unrelated to this project. Dr. Hamedani receives financial support from the National Institutes of Health [Grant #K23EY033438] and the Michael J. Fox Foundation for Parkinson\u2019s Research. Dr. Willis receives financial support from the National Institutes of Health [Grants #1RF1NS132673-01,\u00a0#R01NS099129, #K24AG075234, #RF1NS132673], the Parkinson\u2019s Foundation, Acadia Pharmaceuticals Inc., and the University of Pennsylvania. Mr. Thibault declared no competing interests for this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"325"}}